- Home
- NHC vs BCRX Comparison
NHC vs BCRX Comparison
Compare NHC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHC
- BCRX
- Stock Information
- Founded
- NHC 1971
- BCRX 1986
- Country
- NHC United States
- BCRX United States
- Employees
- NHC N/A
- BCRX N/A
- Industry
- NHC Hospital/Nursing Management
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NHC Health Care
- BCRX Health Care
- Exchange
- NHC Nasdaq
- BCRX Nasdaq
- Market Cap
- NHC 1.7B
- BCRX 1.5B
- IPO Year
- NHC N/A
- BCRX 1994
- Fundamental
- Price
- NHC $98.52
- BCRX $7.45
- Analyst Decision
- NHC
- BCRX Buy
- Analyst Count
- NHC 0
- BCRX 6
- Target Price
- NHC N/A
- BCRX $15.17
- AVG Volume (30 Days)
- NHC 61.9K
- BCRX 2.3M
- Earning Date
- NHC 02-14-2025
- BCRX 02-24-2025
- Dividend Yield
- NHC 2.46%
- BCRX N/A
- EPS Growth
- NHC 174.32
- BCRX N/A
- EPS
- NHC 7.98
- BCRX N/A
- Revenue
- NHC $1,223,271,000.00
- BCRX $412,579,000.00
- Revenue This Year
- NHC N/A
- BCRX $38.01
- Revenue Next Year
- NHC N/A
- BCRX $19.04
- P/E Ratio
- NHC $12.36
- BCRX N/A
- Revenue Growth
- NHC 10.74
- BCRX 29.92
- 52 Week Low
- NHC $87.03
- BCRX $4.03
- 52 Week High
- NHC $138.49
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- NHC 23.19
- BCRX 47.51
- Support Level
- NHC $97.80
- BCRX $7.53
- Resistance Level
- NHC $100.00
- BCRX $8.02
- Average True Range (ATR)
- NHC 2.38
- BCRX 0.44
- MACD
- NHC -0.20
- BCRX -0.06
- Stochastic Oscillator
- NHC 23.46
- BCRX 32.03
About NHC National HealthCare Corporation
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.